Livforsakringsbolaget Skandia Omsesidigt Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Livforsakringsbolaget Skandia Omsesidigt decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,062 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. UnitedHealth Group comprises approximately 1.2% of Livforsakringsbolaget Skandia Omsesidigt’s investment portfolio, making the stock its 13th biggest holding. Livforsakringsbolaget Skandia Omsesidigt’s holdings in UnitedHealth Group were worth $20,972,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Waycross Partners LLC increased its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $515,000. Full Sail Capital LLC increased its position in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the period. Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC increased its position in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after acquiring an additional 12,550 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.0%

UNH opened at $303.08 on Tuesday. The company has a market cap of $274.94 billion, a PE ratio of 19.55, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a 50-day moving average price of $404.62 and a 200 day moving average price of $480.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the company posted $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.92%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on UNH shares. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research report on Thursday, May 15th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Finally, Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $428.43.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.